BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 11699891)

  • 21. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.
    Costello E; Munoz M; Buetti E; Meylan PR; Diggelmann H; Thali M
    Gene Ther; 2000 Apr; 7(7):596-604. PubMed ID: 10819575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
    Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
    J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation.
    Mostoslavsky G; Kotton DN; Fabian AJ; Gray JT; Lee JS; Mulligan RC
    Mol Ther; 2005 Jun; 11(6):932-40. PubMed ID: 15922964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos.
    Pfeifer A; Ikawa M; Dayn Y; Verma IM
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2140-5. PubMed ID: 11854510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
    Zhao J; Pettigrew GJ; Thomas J; Vandenberg JI; Delriviere L; Bolton EM; Carmichael A; Martin JL; Marber MS; Lever AM
    Basic Res Cardiol; 2002 Sep; 97(5):348-58. PubMed ID: 12200634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of HIV as a gene transfer vector.
    Pluta K; Kacprzak MM
    Acta Biochim Pol; 2009; 56(4):531-95. PubMed ID: 19936329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.
    Bai Y; Soda Y; Izawa K; Tanabe T; Kang X; Tojo A; Hoshino H; Miyoshi H; Asano S; Tani K
    Gene Ther; 2003 Aug; 10(17):1446-57. PubMed ID: 12900759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
    Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
    Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroviral vectors for vaccine development: induction of HIV-1-specific humoral and cellular immune responses in rhesus macaques using a novel MLV(HIV-1) pseudotype vector.
    Neumann J; Stitz J; König R; Seibold E; Norley S; Flory E; Cichutek K
    J Biotechnol; 2006 Jul; 124(3):615-25. PubMed ID: 16563543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
    Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
    Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular trafficking of retroviral vectors: obstacles and advances.
    Anderson JL; Hope TJ
    Gene Ther; 2005 Dec; 12(23):1667-78. PubMed ID: 16292352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety features of retroviral vectors.
    Hansen AC; Pedersen FS
    Curr Opin Mol Ther; 2002 Aug; 4(4):324-33. PubMed ID: 12222870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
    Dropulic B
    Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells.
    Temme A; Morgenroth A; Schmitz M; Weigle B; Rohayem J; Lindemann D; Füssel M; Ehninger G; Rieber EP
    Gene Ther; 2002 Nov; 9(22):1551-60. PubMed ID: 12407427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors.
    Berger G; Goujon C; Darlix JL; Cimarelli A
    Gene Ther; 2009 Jan; 16(1):159-63. PubMed ID: 18668143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY
    Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transduction of human embryonic stem cells by ecotropic retroviral vectors.
    Koch P; Siemen H; Biegler A; Itskovitz-Eldor J; Brüstle O
    Nucleic Acids Res; 2006; 34(18):e120. PubMed ID: 16998181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.